About the role#
This co-op position joins the Biomarker Discovery group within the Immunology and Respiratory Research therapeutic area. You will work alongside scientists to study the altered signaling and functional responses of patient-derived fibroblasts. The research focuses on disease pathogenesis, including mechano-sensing, cellular signaling, and fibroblast-immune cell interactions. You will also support translational pharmacology by connecting preclinical models to Phase I clinical trials through biomarker discovery.
What you'll do#
- Characterize SSc patient-derived fibroblasts to identify dysregulation in receptors, signaling pathways, and cellular function.
- Support target engagement and pharmacodynamic biomarker discovery efforts.
- Analyze experimental data and communicate results clearly.
- Maintain accurate records according to company policies and standard operating procedures.
- Demonstrate a strong understanding of immunology and cellular biology.
What you'll need#
- Current enrollment as a graduate or advanced degree student in good academic standing.
- Major related to immunology, fibrosis, cellular biology, or molecular biology.
- Completion of at least 9 credit hours at your current institution.
- Preferred cumulative GPA of 3.0 or higher.
- Legal authorization to work in the United States without restriction.
- Willingness to complete a drug test and post-offer physical if required.
- Experience with cell lines or primary cell culture.
- Proficiency with in vitro assays such as flow cytometry, Western blot, qPCR, or ELISA.
- Ability to troubleshoot independently and work within a team.
Location & details#
- Location: Ridgefield, Connecticut.
- Term: Fall 2026.
- Modality: On-site.
- This is a paid, full-time position.
About Boehringer Ingelheim
Boehringer Ingelheim develops pharmaceutical products for humans and animals. The company operates within the pharmaceutical manufacturing industry. It was founded in 1885 and maintains its headquarters in Ingelheim am Rhein, Germany. The organization is privately held and employs over 10,000 people.
How to get in at Boehringer Ingelheim
Applying early to Boehringer Ingelheim gives you a clear advantage before the applicant pool becomes unmanageable. Intern Insider sends an instant alert the moment a role matching your target is published anywhere, so you apply among the first and get seen before the pile grows. Reaching out to the right people often yields better results than submitting to a general queue. Intern Insider surfaces the recruiters behind the company roles so you can contact them directly to ask about the position or a referral, which materially improves your response rates.
